FILE – This April 28, 2010, file photo shows the GlaxoSmithKline offices in London. On July 20, 2018, the Food and Drug Administration approved GlaxoSmithKline’s Krintafel, a one-dose treatment to prevent relapses of malaria. AP PhotoKirsty Wigglesworth, File ASSOCIATED PRESS The Food and Drug Administration’s FDA Priority Review Vouchers PRVs for neglected tropical diseases NTDs…
Month: April 2019
Health ministry to amend Rule 65 of D&C to replace ‘Chemists & Druggists’ with ‘Pharmacy’
In order to give retail trade a better professional recognition, the Union health ministry will soon amend Rule 6515b and Rule 6515c of Drugs and Cosmetics D&C Rules, to replace ‘Chemists & Druggists’ with ‘Pharmacy’. Once the amendment is done, all the medical shops in the country will be called as Pharmacy. This is also…
The Week Ahead: Medicine manufacturers and middlemen
For the second time in two weeks, the price of insulin will be under scrutiny on Capitol Hill in the week ahead. On Tuesday, the trio of companies making insulin in the U.S. is due before a House subcommittee that has seized on the diabetes medicine as definitive evidence of prescription drug prices spiraling out…